WebMar 31, 2024 · Xiang Shu is the Deputy General Manager of the Marketing Center of the China National Biotec Group Company Limited (CNBG), where he oversees vaccine marketing for private markets and international trade business. Mr Shu has more than 15 years’ experience in CNBG with broad professional knowledge and practice in the … WebJun 22, 2024 · The Phase I/II clinical trials of the world's first inactivated COVID-19 vaccine, developed by Wuhan Institute of Biological Products under the China National Biotec Group (CNBG) affiliated to the ...
China coronavirus vaccine maker gets approval for final stage of human ...
WebJan 21, 2024 · The China-made China National Biotec Group (CNBG) COVID-19 vaccine is broad-spectrum and can cross-neutralize different coronavirus strains, said a senior … WebChina National Biotec Group (CNBG), is a subsidiary of China National Pharmaceutical Group corporation (SINOPHARM), and has 6 subordinate biological products research institutes in Beijing, Changchun, Chengdu, … highlands baseball ocala
CHINA NATIONAL BIOTEC GROUP CO - The Economic Times
WebDec 7, 2024 · China National Biotec Group Company Limited Investments & Acquisitions (8) Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner; ToCell: 10-Mar-2024: Later Stage VC: … WebJan 11, 2024 · China National Biotec Group (CNBG) , told China National Radio that the company was testing how well the vaccine could induce immune response among the younger population and hoped to make it ... WebAug 12, 2024 · China National Biotec Group Company Limited: ClinicalTrials.gov Identifier: NCT04510207 Other Study ID Numbers: CNBG2024003SQ : First Posted: … how is low potassium treated